FRIDAY, Oct. 22, 2021 (HealthDay News) — A lower dose of Pfizer’s coronavirus vaccine is 90.7% effective in preventing symptomatic COVID-19 in children aged 5 to 11, according to new clinical trial data from the company. The data was given to the U.S. Food and Drug Administration on Friday, andContinue Reading

THURSDAY, Oct. 21, 2021 (HealthDay News) — The Pfizer-BioNTech vaccine booster restored close to full protection against COVID-19 in a late-stage trial involving 10,000 people, the company announced Thursday. They said the booster was 95.6% effective and that they plan to submit the latest data to the U.S. Food andContinue Reading

THURSDAY, Oct. 21, 2021 (HealthDay News) — It’s a drug that’s been supported by some conservative media figures, but taking ivermectin to treat or prevent COVID-19 might land you in the hospital, a new study warns. Interest in the drug surged last summer as the highly contagious Delta variant tookContinue Reading

WEDNESDAY, Oct. 20, 2021 (HealthDay News) — Obese people have a tougher time fighting COVID-19, even if they have a milder form of the virus, a new study finds. Researchers looked at more than 500 patients who tested positive for COVID but didn’t require hospitalization. Teens and adults who wereContinue Reading